Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
33 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsScientific Clinical | NANOBIOTIX: the Independent Data Monitoring Committee recommends the continuation of the ongoing phase II/III trial of NBTXR3 in Soft Tissue Sarcoma
(WorldNews France)

 
 

23 march 2017 19:46:26

 
Scientific Clinical | NANOBIOTIX: the Independent Data Monitoring Committee recommends the continuation of the ongoing phase II/III trial of NBTXR3 in Soft Tissue Sarcoma
(WorldNews France)
 


NANOBIOTIX: THE INDEPENDENT DATA MONITORING COMMITTEE RECOMMENDS THE CONTINUATION OF THE ONGOING PHASE II/III TRIAL OF NBTXR3 IN SOFT TISSUE SARCOMA Paris, France and Cambridge, Massachusetts, USA, March 23, 2017 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the local treatment of cancer, today announced that the Independent Data Monitoring Committee (IDMC) has completed the interim evaluation of the Phase II/III trial results (Act.In.Sarc) of NBTXR3 in soft tissue sarcoma. The interim evaluation was based on an analysis of the results of two-thirds of the patients included in the Phase II/III study - 104 patients...


 
1 viewsCategory: General > Europe > France
 
Let´s celebrate the 2017 World Water Day with the E´CHLOTM kits made by Photalia (Vergnet subsidiary) !
(WorldNews France)
Gender discrimination : science is no exception
(WorldNews France)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten